Vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation. Issue 7 (20th June 2017)

Record Type:: Journal Article
Title:: Vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation. Issue 7 (20th June 2017)
Main Title:: Vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation
Authors:: Wright, Andrew P.
Fontana, Robert J.
Stidham, Ryan W.
Abstract:
Is Part Of:: Liver transplantation. Volume 23:Issue 7(2017:Jul.)
Journal:: Liver transplantation
Issue:: Volume 23:Issue 7(2017:Jul.)
Issue Display:: Volume 23, Issue 7 (2017)
Year:: 2017
Volume:: 23
Issue:: 7
Issue Sort Value:: 2017-0023-0007-0000
Page Start:: 968
Page End:: 971
Publication Date:: 2017-06-20
Subjects:: Liver -- Transplantation -- Periodicals
Liver -- Diseases -- Periodicals
Liver Transplantation -- Periodicals
Foie -- Greffe -- Périodiques
617.5560592
Journal URLs:: https://journals.lww.com/lt/pages/currenttoc.aspx#232431391 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/lt.24757 ↗
Languages:: English
ISSNs:: 1527-6465
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5280.522000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 1032.xml